when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Novo Nordisk Inc · news · pharmadog

← back to Novo Nordisk Inc

News mentioning Novo Nordisk Inc

165 stories

11hRoche pours $750M into Oregon manufacturing plant as obesity push expandsbiospace

1dAmylin design debate heats up as Lilly's crucial mid-stage weight loss data nearendpoints

1dKolon TissueGene cuts 37 US staffers after Phase 3 failbiospace

1d11 companies hiring in New Jerseybiospace

1dSTAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and morestat

1dEnveda’s exercise-simulating obesity tablet clears early clinical testbiospace

1dAmylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, morebiospace

2dNovo takes first round of oral obesity duel. Can it stay ahead of Lilly?biospace

2dAmylyx’s bet on a GLP-1 blocker pays offbiopharma dive

2dAmylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemiabiospace

3dSTAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and morestat

4dBaylor Genetics hit by cybersecurity attack targeting patient, staff informationfiercebiotech

6dSkye and Redx form new entity with $125M to advance fibrosis assetsfiercebiotech

7dChutes & Ladders—Former Legend CEO lands at K2fiercebiotech

7dSTAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and morestat

8dLilly files six lawsuits in bid to shut down ‘black market’ for retatrutidebiopharma dive

8d7 companies hiring in North Carolina nowbiospace

8dReplimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlightbiospace

9dWith tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentbiospace

9dScholar Rock rejigs approval filing after FDA flags violations at Novo plantbiospace

10dRevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 winendpoints

10dScholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drugfiercebiotech

11dNovo Nordisk and Amazon sign AI drug discovery pact, launch London innovation hubfiercebiotech

13dSTAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and morestat

13dIs the biotech capital of the world moving?stat

13dNovo Nordisk’s CFO on the oral Wegovy rollout and beyondfiercebiotech

15dNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsglobenewswire health

15dNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsglobenewswire health

15dThe top 12 companies hiring in biopharma nowbiospace

15dActimed gets back rights to wasting disease drug, ending $126M deal with Faradayfiercebiotech

← prevpage 1 of 6next →